期刊文献+

他克莫司滴眼液的质量控制及稳定性考察 被引量:2

原文传递
导出
摘要 目的:建立他克莫司滴眼液的质量控制方法,并考察其稳定性。方法:根据中国药典2005年版眼用制剂项下规定建立他克莫司滴眼液的质量控制方法,用高效液相色谱法测定他克莫司的含量,采用经典恒温加速试验法考察该制剂对热的稳定性。结果:他克莫司在6.25~200mg·L^-1范围内线性关系良好(r=0.9999),平均回收率为98.94%,RSD为0.89%(n=8),方法重复性的RSD为1.28%(n=6),他克莫司滴眼液对热的稳定性较差,预测25℃贮存有效期为46.68d,而4℃贮存有效期约2.55年。结论:采用高效液相色谱法测定他克莫司的含量简便、精密、可行。他克莫司滴眼液需低温保存。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第22期1951-1952,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献9

  • 1Altas-Fox L, Barkana Y, Iskhakov V. et al. Topical tacroli mus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study[J]. Curr Eye Res,2008,33(7):545- 549.
  • 2史伟云,刘廷,谢立信,王身国.FK506缓释系统前房植入抑制兔高危角膜移植术后的免疫排斥反应[J].中华眼科杂志,2006,42(4):299-304. 被引量:18
  • 3Keiko OI, Hiroshi K, Hiroshi G, et al. Upregulation of neurotrophic factor-related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of lacroli mus (FK5(16) [J ]. Br J Ophthalmol, 2(107.91 ( 11 ) : 1537-1540.
  • 4费文雷,陈家祺,庞志清,骆新兰,刘永民,王铮,袁进,蔡秀玲.FK506纳米粒对大鼠角膜移植排斥反应的影响[J].眼科研究,2006,24(2):156-159. 被引量:10
  • 5陈剑,周清,徐锦堂,王彦平,赵松滨.FK506滴眼液抑制兔同种异体角膜缘移植排斥反应的免疫病理学研究[J].中国实用眼科杂志,2003,21(9):696-698. 被引量:5
  • 6中国药典.二部[S].2005.附录:29.
  • 7Staatz CE, Taylor PJ, Tett SE. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipienls[J]. Ther Drug Monit,2002,24(5):607- 615.
  • 8Freire A, Hermida J, Tutor J. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays[J]. Ups J Med Sci, 2008, 113(1):103- 110.
  • 9Westley IS, Taylor PJ, Salm P, etal. Cloned enzyme donor im munoassay tacrolimus assay compared with high performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients[J]. Ther Drug Monit,2007,29(5):584 -591.

二级参考文献16

  • 1Kataoka T, Nagai K. Involvement of FKS06 sensitive and insensitive granule exocytosis pathways in perforin - dependent target cell lysi smediated by a CD8 + CTL clone. Immunology letters 2000 72:49-- 52.
  • 2Swift GJ, Aggarwal RK, Davis GJ, et al. Survival o[ rabbit limbal stem cell allografts. Transplantation 1996 62 (5) : 568-578.
  • 3Ke- ping Xu, Ying Wu, Jian Zhou, et al. Survival of rabbit limbal stem cell allografts after administration of cyclosporin A. Cornea 1999 18 (4): 459--467.
  • 4Morris R. Modes of action of FKS06, Cyclosporie A, and rapamycin. Transplant Proc 1994 26 : 3272-- 3275.
  • 5SestakK, Lee JH, Brisben J, et al. Tacrolimus-FKS06 induced immunosuppression in gnotobiotic piglets. Veterinary immunology and immunooathology 2000 77:289--300.
  • 6Tangsinmankong N, Day NK, Good RA, et al. Different mechanisms are utilized by H1V- 1Nef and staphylococcal enterotoxin A to control and regulate interleukin- 10 production. Immunology letters 2002 84:97--101.
  • 7Sloper CM, Power RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology,2001,108 : 1838-1844.
  • 8Richard A, Dan B, Curtis R, et al. Topical FK506 prevents experimental corneal allograft rejection. Cornea, 1995,14 : 157-160.
  • 9MacPhee IA, Fredericks S, Tai T. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am J Transplant,2004,4:914-919.
  • 10Tocci MJ, Makovich DA, Collier KA, et al. The immunceuppressant FK506 selectively inhibits expression of early T cell activation genens. J Immunol, 1989,143 : 718-726.

共引文献125

同被引文献6

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部